mis

Hot Keywords
Non-small cell lung cancer Artificial intelligence Gastroesophageal reflux Esophagectomy Thoracic surgery Atherosclerosis Robotic surgery Gastric cancer Lung cancer Lobectomy Complications Quality of life Rectal cancer

Top
Topic: Current and Future Treatment of Hepatocellular Carcinoma

A special issue of Mini-invasive Surgery

ISSN 2574-1225 (Online)

Submission deadline: 25 Oct 2022

Guest Editor(s)

  • Prof. Zenichi Morise
    Department of Surgery, Fujita Health University School of Medicine Okazaki Medical Center, Toyoake, Japan.

    Website | E-mail

Special Issue Introduction

Minimally invasive liver surgery (MILS) for hepatocellular carcinoma (HCC) has attracted considerable attention as an alternative to traditional open liver surgery (OLS). There are two main aspects of minimally invasive techniques for HCC: minimally invasive hepatectomy, such as laparoscopic hepatectomy, robotic-assisted hepatectomy, etc; partial and regional non-surgical resection, such as transhepatic artery treatment, microwave ablation, percutaneous ablation, etc.. However, the long-term and short-term survival benefits of this minimally invasive approach are unclear. In addition, in different tumor stages of HCC, how to choose to maximize the effect of each minimally invasive technique is a skill that every contemporary doctor should master. Therefore, this special issue aims to collect the researche from the leading experts around the world, discuss the current difficulties and future perspectives, explore different minimally invasive treatment techniques to improve prognosis and make evidence-based treatment decisions.

This special issue will discuss topics including but not limited to:
1. Laparoscopic liver resections for hepatocellular carcinoma;
2. Minimally invasive surgery in liver transplantation for hepatocellular carcinoma;
3. Robotic liver resection for hepatocellular carcinoma;
4. Microwave ablation for treatment of hepatocellular carcinoma and liver metastases;
5. Percutaneous ablation for hepatocellular carcinoma;
6. Transhepatic arterial therapy for hepatocellular carcinoma;
etc.

Submission Deadline

25 Oct 2022

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://misjournal.net/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=mis&SpecialIssueId=mis220425
Submission Deadline: 25 Oct 2022
Contacts: Judith Duan, Assistant Editor, miniinvasive.editor@misjournal.net

Published Articles

none
© 2016-2022 OAE Publishing Inc., except certain content provided by third parties